FNY Managed Accounts’s Neurocrine Biosciences NBIX Stock Holding History

FNY Managed Accounts’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-43	Closed	-$3K	–	755
2017 Q4	$3K	Buy	+43	New	+$2.93K	﹤0.01%	430
2017 Q2	–	Sell	-82	Closed	-$3K	–	451
2017 Q1	$3K	Buy	+82	New	+$3.51K	0.01%	686

Other funds holding NBIX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FNY Managed Accounts's NBIX Position: Q1 2018 in Review

FNY Managed Accounts sold out of Neurocrine Biosciences (NBIX) in Q1 2018, closing a stake of 43 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in NBIX in Q1 2017 and held it in 2 quarters. The position peaked at $3K in Q4 2017. 266 funds tracked by Wall St. Rank hold NBIX as of Q1 2018.

FNY Managed Accounts reported no remaining Neurocrine Biosciences position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 43 Neurocrine Biosciences shares in Q1 2018, an estimated $3K.
FNY Managed Accounts first reported a position in Neurocrine Biosciences in Q1 2017 and held it in 2 quarters.
FNY Managed Accounts's Neurocrine Biosciences position peaked at $3K in Q4 2017.
266 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.